These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31056435)

  • 21. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
    Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
    BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of the lymphovascular invasion in high-grade stage pT1 bladder cancer.
    Branchereau J; Larue S; Vayleux B; Karam G; Bouchot O; Rigaud J
    Clin Genitourin Cancer; 2013 Jun; 11(2):182-8. PubMed ID: 23276589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
    Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
    BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.
    Ge P; Wang ZC; Yu X; Lin J; He Q
    BMC Urol; 2015 May; 15():46. PubMed ID: 26025446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
    Quek ML; Stein JP; Nichols PW; Cai J; Miranda G; Groshen S; Daneshmand S; Skinner EC; Skinner DG
    J Urol; 2005 Jul; 174(1):103-6. PubMed ID: 15947587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
    Bolenz C; Herrmann E; Bastian PJ; Michel MS; Wülfing C; Tiemann A; Buchner A; Stief CG; Fritsche HM; Burger M; Wieland WF; Höfner T; Haferkamp A; Hohenfellner M; Müller SC; Ströbel P; Trojan L
    BJU Int; 2010 Aug; 106(4):493-9. PubMed ID: 20067452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological factors associated with survival benefit from adjuvant chemotherapy (ACT): a population-based study of bladder cancer.
    Booth CM; Siemens DR; Wei X; Peng Y; Berman DM; Mackillop WJ
    BJU Int; 2015 Sep; 116(3):373-81. PubMed ID: 25168574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis.
    Zhang L; Wu B; Zha Z; Zhao H; Yuan J; Jiang Y
    World J Urol; 2020 Jan; 38(1):129-142. PubMed ID: 30919100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of lymphovascular invasion in radical cystectomy on patients with bladder cancer: a systematic review and meta-analysis.
    Kim H; Kim M; Kwak C; Kim HH; Ku JH
    PLoS One; 2014; 9(2):e89259. PubMed ID: 24586637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
    Giacalone NJ; Shipley WU; Clayman RH; Niemierko A; Drumm M; Heney NM; Michaelson MD; Lee RJ; Saylor PJ; Wszolek MF; Feldman AS; Dahl DM; Zietman AL; Efstathiou JA
    Eur Urol; 2017 Jun; 71(6):952-960. PubMed ID: 28081860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.
    Martin JW; Vernez SL; Lotan Y; Abdelhalim A; Dutta R; Shokeir A; Abol-Enein H; Mosbah A; Ghoneim M; Youssef RF
    World J Urol; 2018 Nov; 36(11):1835-1843. PubMed ID: 29761225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients With Muscle-Invasive Bladder Cancer With Lymphovascular Invasion in Transurethral Resection Specimen Benefits Most From Platinum-Based Neoadjuvant Chemotherapy.
    Wang Z; He W; Ying Y; Wang M; Chen Q; Zhang Z; Zeng S; Xu C
    Clin Genitourin Cancer; 2024 Apr; 22(2):201-209.e7. PubMed ID: 37989709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Immediate Radical Cystectomy Necessary for All Patients with Non-Muscle-Invasive Micropapillary Bladder Cancer?
    Jackson BL; Mohammed A; Mayer N; Dormer J; Griffiths TR
    Urol Int; 2016; 96(1):32-8. PubMed ID: 25924623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
    Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A;
    BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer.
    Kimura S; D' Andrea D; Soria F; Foerster B; Abufaraj M; Vartolomei MD; Iwata T; Karakiewicz PI; Rink M; Gust KM; Egawa S; Shariat SF
    Urol Oncol; 2019 Mar; 37(3):179.e19-179.e28. PubMed ID: 30580906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
    Kassouf W; Spiess PE; Brown GA; Munsell MF; Grossman HB; Siefker-Radtke A; Dinney CP; Kamat AM
    Eur Urol; 2007 Sep; 52(3):769-74. PubMed ID: 17434254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens.
    Mari A; Kimura S; Foerster B; Abufaraj M; D'Andrea D; Hassler M; Minervini A; Rouprêt M; Babjuk M; Shariat SF
    BJU Int; 2019 Jan; 123(1):11-21. PubMed ID: 29807387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of
    Ecke TH; Kiani A; Schlomm T; Friedersdorff F; Rabien A; Jung K; Kilic E; Boström P; Tervahartiala M; Taimen P; Gleichenhagen J; Johnen G; Brüning T; Koch S; Roggisch J; Wirtz RM
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.